Gut microbiota and clinical disease: obesity and nonalcoholic Fatty liver disease

Pediatr Gastroenterol Hepatol Nutr. 2013 Mar;16(1):22-7. doi: 10.5223/pghn.2013.16.1.22. Epub 2013 Mar 31.

Abstract

The prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia, hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Many environmental or genetic factors have been suggested to contribute to the development of obesity, but there is no satisfactory explanation for its increased prevalence. This review discusses the latest updates on the role of the gut microbiota in obesity and NAFLD.

Keywords: Microbiota; Non-alcoholic fatty liver disease; Obesity.

Publication types

  • Review